For the most recent month-end and standardized performance, please call 646-661-5441 or visit the Funds website: We see several powerful tailwinds underpinning the GLP-1 and weight-loss drug revolution: Market leaders are grappling to take share and deliver strong growth, reflected in both expanding revenue and strong equity performance
Activating the GSH system alleviates the progression of the myocardial injury by blocking the ferroptosis pathway and oxidative stress, which provides a promising therapeutic strategy for cardiac diseases
19 Belcaro G, Ledda A, Hu S, Cesarone MR, Feragalli B, Dugall M
Start at the lower end, check tolerance, and reassess after 812 weeks
They achieve different endpoints